Mortality Attributable to Hepatitis B and C in Italy, Romania, and Spain, 2022 Estimates
Oleksandr Korotych, Helene Høgsbro Thygesen, Otilia Mårdh, Juliana Reyes‐Urueña et autres
0 citationsLiver International
Mirela Chitul
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
17Publications signalées
11Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Hepatitis C virus researchHepatitis B Virus StudiesLiver Disease Diagnosis and TreatmentLiver Disease and TransplantationHepatocellular Carcinoma Treatment and Prognosis
Publications récentes
TOP-582 Bulevirtide monotherapy prevents liver decompensation in patients with hdv-related cirrhosis: a case control study with propensity score weighted analysis
Elisabetta Degasperi, Annalisa De Silvestri, Dominique Roulot, Maria Paola Anolli et autres
0 citationsJournal of Hepatology
WED-015 Assessing the economic value of bulevirtide for chronic hepatitis delta in Romania: combining real-world patient data with a markov state-transition model
Liana Gheorghe, Speranta Iacob, Mihaela Ghioca, Mirela Chitul et autres
0 citationsJournal of Hepatology
FRI-585-YI Performances of the page-b and amap scores to predict hepatocellular carcinoma in patients with compensated delta cirrhosis treated long-term with bulevirtide monotherapy (save-d study)
Maria Paola Anolli, Elisabetta Degasperi, Dana Sambarino, Marta Borghi et autres
0 citationsJournal of Hepatology
OS-066 Long-term virological and clinical outcomes in patients with hdv-related cirrhosis treated with bulevirtide monotherapy for up to 4 years (save-d study)
Elisabetta Degasperi, Maria Paola Anolli, Dana Sambarino, Marta Borghi et autres
0 citationsJournal of Hepatology
FRI-601 Real-world 12-month outcomes of Bulevirtide therapy in chronic hepatitis D: interim results from a prospective romanian cohort
Liana Gheorghe, Mihaela Ghioca, Mirela Chitul, Anca Trifan et autres
0 citationsJournal of Hepatology
Hepatocellular Carcinoma in Delta Hepatitis Versus HBV Monoinfection: Spot the Differences
Răzvan Cerban, Mirela Chitul, Speranta Iacob, Liana Gheorghe
0 citationsLivers
Identifying Risk Factors for Hepatocellular Carcinoma in Patients With Delta Hepatitis: A Prognostic Study
Speranta Iacob, Mirela Chitul, Diana Stan, Mugur Grasu et autres
0 citationsJournal of Viral Hepatitis
WED-091 Delta hepatitis versus HBV monoinfection associated hepatocellular carcinoma: spot the difference
Mirela Chitul, Răzvan Cerban, Speranta Iacob, Diana Stan et autres
1 citationJournal of Hepatology
THU-262 Quality of life in HDV-infected patients prior to bulevirtide treatment: chronic hepatitis versus compensated cirrhosis
Mirela Chitul, Speranța Iacob, Mihaela Ghioca, Carmen Ester et autres
0 citationsJournal of Hepatology
WED-291 Long risk of decompensation and HCC in patients with HDV- related compensated cirrhosis treated with Bulevirtide monotherapy for up to 144 weeks: the retrospective multicenter european study (Save-D)
Elisabetta Degasperi, Maria Paola Anolli, Liana Gheorghe, Mirela Chitul et autres
4 citationsJournal of Hepatology
Liver Elastography Methods for Diagnosis of De Novo and Recurrent Hepatocellular Carcinoma
Răzvan Cerban, Speranta Iacob, Carmen Ester, Mihaela Ghioca et autres
0 citationsDiagnostics
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.